Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Reck

Showing results (31-40 of 437) with videos related to

Pageof 44
Sort By:
The New England Journal of Medicine|March 9, 2017
Pembrolizumab in Non-Small-Cell Lung CancerMartin Reck, Julie R Brahmer
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
CrizotinibDavid F Heigener, Martin Reck
Advances in Therapy|December 25, 2010
Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinibDavid F Heigener, Martin Reck
Journal of Thoracic Disease|June 29, 2018
Advanced non-small cell lung cancer: the role of PD-L1 inhibitorsDavid F Heigener, Martin Reck
The New England Journal of Medicine|November 16, 2017
Advanced Non-Small-Cell Lung CancerMartin Reck, Klaus F Rabe
The New England Journal of Medicine|August 31, 2017
Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung CancerMartin Reck, Klaus F Rabe
Deutsches Arzteblatt International|November 16, 2023
In ReplyMartin Reck, Jens Vogel-Claussen
Drugs|November 22, 2019
Immune Checkpoint Inhibition in Non-metastatic Non-small Cell Lung Cancer: Chance for Cure?David F Heigener, Martin Reck
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
CrizotinibDavid F Heigener, Martin Reck
The Lancet. Respiratory Medicine|December 19, 2015
Immunotherapy: the third wave in lung cancer treatmentDavid Felix Heigener, Martin Reck
Pageof 44

Showing results (31-40 of 437) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|March 9, 2017
Pembrolizumab in Non-Small-Cell Lung CancerMartin Reck, Julie R Brahmer
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
CrizotinibDavid F Heigener, Martin Reck
Advances in Therapy|December 25, 2010
Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinibDavid F Heigener, Martin Reck
Journal of Thoracic Disease|June 29, 2018
Advanced non-small cell lung cancer: the role of PD-L1 inhibitorsDavid F Heigener, Martin Reck
The New England Journal of Medicine|November 16, 2017
Advanced Non-Small-Cell Lung CancerMartin Reck, Klaus F Rabe
The New England Journal of Medicine|August 31, 2017
Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung CancerMartin Reck, Klaus F Rabe
Deutsches Arzteblatt International|November 16, 2023
In ReplyMartin Reck, Jens Vogel-Claussen
Drugs|November 22, 2019
Immune Checkpoint Inhibition in Non-metastatic Non-small Cell Lung Cancer: Chance for Cure?David F Heigener, Martin Reck
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
CrizotinibDavid F Heigener, Martin Reck
The Lancet. Respiratory Medicine|December 19, 2015
Immunotherapy: the third wave in lung cancer treatmentDavid Felix Heigener, Martin Reck
Pageof 44